Legendary licenses

Scienmag

Licensing expert Bob Westervelt, who has worked to transfer Sandia National Laboratories technologies in the medical, solar and hydrogen production fields, received the 2021 Outstanding Technology Transfer Professional Award from the Federal Laboratory Consortium.

Merck pays $250M to license Moderna cancer vaccine

Bio Pharma Dive

The drugmaker’s decision to grab rights to the shot deepens its ties with the COVID-19 vaccine developer and comes weeks before a key data release

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Biogen licenses a stroke drug from Japanese drugmaker TMS

Bio Pharma Dive

The drug, which Biogen had an option to license, is one of two in the biotech's pipeline for a condition that has had few new treatments developed

Lava fires up a $700m cancer licensing deal with Seagen

Pharma Phorum

While a rumoured takeover by Merck & Co has yet to materialise, Seagen is getting on with its own business development, including a just-agreed licensing deal for a cancer immunotherapy developed by Dutch biotech Lava Therapeutics.

China-based biotech licenses Sanofi's RNA drug technology

Bio Pharma Dive

The Lilly-backed Rona Therapeutics gains rights to a platform for small interfering RNA, along with a slate of preclinical candidates aimed at targets in the liver and other tissues

RNA 207

Should e-cigarettes be licensed as medicines?

Scienmag

Latest News Ecigarettes licensed MedicinesNicholas Hopkinson at Imperial College London welcomes the move, saying this will give doctors another means to help smokers quit. E-cigarettes are currently regulated as consumer products so cannot be promoted as smoking cessation aids, he explains. Yet a Cochrane review already supports existing e-cigarettes as a smoking cessation aid, as does recently updated guidance […].

Purdue invention to improve health and welfare of farrowing sows is licensed to Canadian company

Scienmag

and WINNIPEG, Manitoba — A patented Purdue University invention designed to cool sows and lower their respiration rate while farrowing has been licensed to Innovative Heating Technologies for further beta testing and commercialization. WEST LAFAYETTE, Ind.,

Harvard Wyss Institute’s eRapid sensor technology licensed to Antisoma Therapeutics to facilitate infectious and immune disease and cancer diagnostics

Scienmag

announced that the Institute’s electrochemical eRapid technology has been licensed to Antisoma Therapeutics Pty. Medicine & Health Antisoma cancer Diagnostics Disease eRapid facilitate Harvard immune infectious Institutes licensed sensor technology therapeutics Wyss

Harvard Wyss Institute’s eRapid multiplexed biosensor technology licensed to StataDX to enable new diagnostics for neurological, cardiovascular, and renal diseases

Scienmag

announce that the Wyss Institute’s affinity-based, multiplexed, electrochemical sensing technology, eRapid, has been licensed to the startup. The license, coordinated by Harvard’s Office of Technology Development (OTD), grants StataDX exclusive worldwide access to […].

NIH licenses COVID-19 technologies to WHO-backed program

Bio Pharma Dive

The agreement, which covers three experimental vaccines as well as several key patents, will be royalty free for products sold in 49 low-income countries

TherapeuticsMD and Mayne sign product licensing agreements

Pharmaceutical Technology

Women’s healthcare company TherapeuticsMD has sign ed agreements for licensing its products to the Mayne Pharma affiliate in the US. Additionally, TherapeuticsMD will grant Mayne the exclusive license to market Annovera in the US.

Licensing deal aimed at progressing cell and gene therapies in the treatment of rare diseases

BioPharma Reporter

Curamys, a South Korean biotech developing cell and gene therapy using cell fusion technology to treat rare intractable diseases, has signed a strategic platform licensing agreement with US tech developer, MaxCyte.

Merck agrees to license COVID-19 pill widely through pact with patent group

Bio Pharma Dive

The deal with the Medicines Patent Pool is meant to increase access in lower-income countries to molnupiravir, an experimental drug that could become the first oral treatment for COVID-19

Is License Compulsory For Starting Pharmaceutical Business In India?

Fossil Remedies

To launch the best PCD pharma franchise company, you will have to acquire the necessary licenses from authorities. The next important thing is the license. Every pharma company needs a drug license number to begin distribution, marketing, and manufacturing activities.

Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases

Scienmag

Alkem Laboratories Limited (Alkem), an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University’s Office of Technology Development (OTD) enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by […].

Sobi bolsters blood division via $435m ADC licensing deal

Pharma Phorum

Swedish rare disease specialist Sobi is paying $55 million upfront to license rights to ADC Therapeutics’ lymphoma therapy Zynlonta – approved in the US last year – in Europe and other international markets.

Roche deepens ties with Jnana with a second licensing deal

Pharma Phorum

The post Roche deepens ties with Jnana with a second licensing deal appeared first on.

Ignis Health licenses telehealth roadmap from the Medical University of South Carolina

Scienmag

Technology and Engineering Biotechnology Health Care Systems/Services Health Professionals Information Management/Tracking Systems Licenses/Patents Management Science/Operations Research Medicine/Health Technology Transfer Telecommunications

Boston Pharmaceuticals Licenses Potential NASH Treatment from Novartis

BioSpace

Boston Pharmaceuticals licensed the drug candidate BOS-580, an injectable, genetically engineered variant of human FGF21

Biohaven stocks up on experimental drugs with new acquisition, licensing deal

Bio Pharma Dive

Separate agreements with Channel Biosciences and Bristol Myers Squibb give Biohaven access to experimental treatments for spinal muscular atrophy and for epilepsy

Companies Enter Licensing Agreements to Expand Gene Therapy Programs

BioSpace

Takeda entered into a licensing pact with Poseida, Spark entered into a licensing agreement with CombiGene AB, while BridgeBio Pharma announced plans for its second annual R&D Day

LG Chem Renews License Triggering Payment to Avacta

BioTech 365

LG Chem Renews License Triggering Payment to Avacta LG Chem Renews License Triggering Payment to Avacta LG Chem will now proceed with Investigational New Drug (IND) enabling studies for Affimer PD-L1 antagonist programme LONDON & WETHERBY, England–(BUSINESS WIRE)–Avacta Group plc … Continue reading → Business Wire

Avacta Signs Diagnostic Licensing Deal with Biokit

BioTech 365

Halozyme, doubling down on a licensing strategy, buys a drug delivery biotech for nearly $1B

Bio Pharma Dive

Antares Pharma's auto-injector technology is of particular interest to Halozyme, which believes that the various markets to which it could be applied represent billions of dollars in potential sales

Pfizer-licensed Cardiovascular Drug Reduces Triglycerides in Phase II

BioSpace

A cardiovascular drug Pfizer licensed from Akcea Therapeutics in 2019 hit the mark in a Phase IIb dose-ranging study in patients with elevated non-HDL-C and triglycerides

Kite Gains Access to Refuge's Gene Expression Platform in Licensing Deal

BioSpace

Kite Pharma entered into a global licensing deal with Refuge Biotechnologies to leverage the latter's propriety gene expression plaform and develop potential blood cancer therapies

Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction

BioTech 365

Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction Ignis Therapeutics Licenses NeuroSigma eTNS Technology for ADHD in a Significant China Licensing Transaction Ignis obtains rights to develop and commercialize NeuroSigma’s FDA-approved Monarch eTNS System in China … Continue reading → GlobeNewswire

Heritage Granted Health Canada Research License

BioTech 365

Heritage Granted Health Canada Research License Heritage Granted Health Canada Research License TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

BMS Licenses IL-12 from Dragonfly in $475 Million Deal

BioSpace

Bristol Myers Squibb plunked down $475 million for the exclusive license to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy program

VaxAlta Inc. Announces License Agreement With Scandinavian Biopharma

BioTech 365

Announces License Agreement With Scandinavian Biopharma VaxAlta Inc. Announces License Agreement With Scandinavian Biopharma Scandinavian Biopharma has obtained a global license for VaxAlta Inc.’s VaxAlta Inc.

Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement for Digital PCR Applications

Fierce Pharma

Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement for Digital PCR Applications. jpiatt. Wed, 11/09/2022 - 16:38

U.S. FDA Licenses Certara’s Immunogenicity Simulator

BioTech 365

FDA Licenses Certara’s Immunogenicity Simulator U.S. FDA Licenses Certara’s Immunogenicity Simulator Affirms the advancements of innovative biosimulation technology and its growing impact in R&D PRINCETON, N.J., 23, 2022 (GLOBE NEWSWIRE) — Certara, Inc. Nasdaq: CERT), a global leader … Continue reading → GlobeNewswire

The Lundquist Institute out-licenses development of a synthetic lung surfactant formulation

Scienmag

Bill & Melinda Gates Medical Research Institute to develop formulation -AGREEMENT ADVANCES EVOLUTION OF SYNTHETIC LUNG SURFACTANTS TO TREAT RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS IN LOW- AND MIDDLE-INCOME COUNTRIES- LOS ANGELES (March 8, 2021) — The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement […].

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

BioTech 365

Akili adds to ADHD gaming range with £37m TALi licensing deal

Pharma Phorum

Akili already has the first and only FDA cleared video game-based digital therapeutic (DTx) for children with attention-deficit hyperactivity disorder (ADHD), but is looking to add to its range via a licensing deal with Australia’s TALi Digital. .

Ligand and GSK Expand Global Collaboration and License Agreement

BioTech 365

Ligand and GSK Expand Global Collaboration and License Agreement Ligand and GSK Expand Global Collaboration and License Agreement Ligand to receive an upfront payment of $10 million Further leverages the Icagen ion-channel discovery technology to target neurological diseases EMERYVILLE, Calif.–(BUSINESS

Lilly adds to pain pipeline with Asahi Kasei licensing deal

Pharma Phorum

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. The post Lilly adds to pain pipeline with Asahi Kasei licensing deal appeared first on.

Emergence Therapeutics licenses ADC technology platform in $360M deal

BioPharma Reporter

Emergence Therapeutics has become the tenth company to license ADC technology from Synaffix. The deal has a total potential value of up to US$360m, plus royalties on commercial sales. Markets & Regulations

Sales 52

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

BioTech 365

Celogics License in NEXEL’s Cardiosight-S for Global Distribution

BioTech 365

Celogics License in NEXEL’s Cardiosight-S for Global Distribution Celogics License in NEXEL’s Cardiosight-S for Global Distribution SEATTLE–(BUSINESS WIRE)–Celogics, a U.S.-based based manufacturer of human iPSC-derived cell products for therapeutics development and life sciences research, today announced the exclusive licensing of NEXEL’s … Continue reading → Business Wire

Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc

Pharma Mirror

The post Almirall and Simcere enter into a licensing agreement for IL-2-mu-Fc appeared first on Pharma Mirror Magazine.

CinFina Pharma In-Licenses Obesity Portfolio

BioTech 365

CinFina Pharma In-Licenses Obesity Portfolio CinFina Pharma In-Licenses Obesity Portfolio Four novel, once-weekly anorectic agents targeting significant weight loss CINCINNATI, Sept. 22, 2021 (GLOBE NEWSWIRE) — CinFina Pharma, LLC. CinFina”) announced today that it has signed an agreement with Janssen … Continue reading → GlobeNewswire

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement

BioTech 365

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research DUBLIN & PISCATAWAY, N.J.–(BUSINESS

Gene 52